Clifford Bechtold
Compliance Officer bij BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Profiel
Mr. Clifford Bechtold is Chief Operating Officer bij Biohaven Pharmaceutical Holding Co. Ltd. De heer Bechtold was voorheen werkzaam als Vice President-Strategic Operations bij Adnexus en als Staff Director bij Bristol Myers Squibb Co. Hij behaalde zijn doctorale graad aan de South Dakota State University en zijn doctorale graad aan de Creighton University School of Medicine.
Actieve functies van Clifford Bechtold
Bedrijven | Functie | Begin |
---|---|---|
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Compliance Officer | - |
BIOHAVEN LTD. | Compliance Officer | - |
Eerdere bekende functies van Clifford Bechtold
Bedrijven | Functie | Einde |
---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-11-2013 |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01-10-2011 |
Opleiding van Clifford Bechtold
South Dakota State University | Undergraduate Degree |
The Creighton University School of Medicine | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
BIOHAVEN LTD. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Health Technology |
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |